HARVARD BIOSCIENCE INC Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Harvard Bioscience Inc quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • Harvard Bioscience Inc Operating Income (Loss) for the quarter ending September 30, 2024 was -$1.87M, a 101% decline year-over-year.
  • Harvard Bioscience Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was -$5.94M, a 614% decline year-over-year.
  • Harvard Bioscience Inc annual Operating Income (Loss) for 2023 was $1.89M.
  • Harvard Bioscience Inc annual Operating Income (Loss) for 2022 was -$6.93M, a 436% decline from 2021.
  • Harvard Bioscience Inc annual Operating Income (Loss) for 2021 was $2.07M, a 835% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$5.94M -$1.87M -$941K -101% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 -$5M -$2.07M -$2.87M -360% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$2.13M -$2.28M -$4.03M -230% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $1.89M $282K +$739K Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 $1.16M -$933K +$2.83M +75.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 -$1.67M $796K -$3.2M -80.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $1.53M $1.75M +$8.46M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$6.93M -$457K -$2.16M -127% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 -$4.78M -$3.76M -$4.31M -786% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$467K $4M +$3.94M +6793% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$4.41M -$6.71M -$6.47M -2708% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-26
Q4 2021 $2.07M $1.7M -$1.06M -38.4% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 $3.12M $548K +$366K +201% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $2.76M $58K -$498K -89.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $3.26M -$239K +$3.03M +92.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $221K $2.76M +$1.12M +68.8% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 -$902K $182K +$1.55M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 -$2.45M $556K +$328K +144% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 -$2.78M -$3.27M -$3.15M -2628% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $376K $1.63M -$109K -6.26% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-16
Q3 2019 $485K -$1.37M -$2.26M -253% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $2.74M $228K +$610K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $2.13M -$120K +$1.15M +90.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $984K $1.74M +$1.37M +366% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 -$384K $890K +$1.28M Jul 1, 2018 Sep 30, 2018 10-K 2020-03-16
Q2 2018 -$1.66M -$382K -$113K -42% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-16
Q1 2018 -$1.55M -$1.27M -$916K -262% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-16
Q4 2017 -$635K $374K +$1.5M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 -$2.13M -$390K +$423K +52% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-18
Q2 2017 -$2.56M -$269K +$571K +68% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-18
Q1 2017 -$3.13M -$350K -$129K -58.4% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-18
Q4 2016 -$3M -$1.12M -$1.24M -1094% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-16
Q3 2016 -$1.76M -$813K -$38K -4.9% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-16
Q2 2016 -$1.72M -$840K -$939K -948% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-16
Q1 2016 -$784K -$221K +$929K +80.8% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-16
Q4 2015 -$1.71M $113K -$2.01M -94.7% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-17
Q3 2015 $295K -$775K -$2.2M -154% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-17
Q2 2015 $2.5M $99K -$1.64M -94.3% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-17
Q1 2015 $4.13M -$1.15M -$2.48M -186% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-17
Q4 2014 $6.62M $2.12M +$3.07M Oct 1, 2014 Dec 31, 2014 10-K 2016-04-29
Q3 2014 $3.55M $1.43M +$1.01M +244% Jul 1, 2014 Sep 30, 2014 10-K 2016-04-29
Q2 2014 $2.54M $1.74M +$992K +133% Apr 1, 2014 Jun 30, 2014 10-K 2016-04-29
Q1 2014 $1.55M $1.33M +$8K +0.6% Jan 1, 2014 Mar 31, 2014 10-K 2016-04-29
Q4 2013 $1.54M -$949K -$3.09M -144% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-12
Q3 2013 $4.62M $414K -$742K -64.2% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-12
Q2 2013 $5.37M $746K -$1.73M -69.8% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-12
Q1 2013 $7.09M $1.33M -$736K -35.7% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-12
Q4 2012 $7.83M $2.14M +$750K +54% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-14
Q3 2012 $7.08M $1.16M +$936K +425% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-14
Q2 2012 $6.14M $2.47M -$45K -1.79% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-14
Q1 2012 $6.19M $2.06M +$112K +5.74% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-14
Q4 2011 $6.08M $1.39M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-18
Q3 2011 $220K -$1.72M -88.7% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-18
Q2 2011 $2.52M +$147K +6.2% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-18
Q1 2011 $1.95M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-18
Q3 2010 $1.94M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-09
Q2 2010 $2.37M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.